Acute renal failure after liver transplantation in MELD era

Area of Science:

• Nephrology
• Hepatology
• Transplantation

Background:

• The Model for End-Stage Liver Disease (MELD) score is utilized for prioritizing liver transplant candidates.
• Renal function is a critical factor in the MELD score's assessment of disease severity.
• Evaluating the impact of the MELD score on renal function post-orthotopic liver transplantation (OLT) is crucial.

Purpose of the Study:

• To investigate the effect of the MELD scoring system on renal function and therapeutic strategies in OLT recipients.
• To compare the incidence of acute renal failure (ARF) and mortality rates before and after the MELD era.
• To identify predictors of ARF following OLT.

Main Methods:

• Retrospective analysis of two patient cohorts undergoing OLT: pre-MELD (n=240) and post-MELD (n=224).
• Assessment of acute renal function (ARF) requiring renal replacement therapy (hemofiltration or hemodialysis).
• Statistical analysis to determine predictors of ARF, including pre-OLT creatinine, blood transfusion rates, and intraoperative diuresis.

Main Results:

• The incidence of ARF post-OLT was 8.3% in the pre-MELD group and 13% in the MELD group.
• Mortality rates were 40% in the pre-MELD group and 27% in the MELD group.
• Pre-OLT creatinine levels, blood transfusion rates, and intraoperative diuresis were significant predictors of ARF, but MELD score did not correlate with postoperative ARF.

Conclusions:

• While the MELD score did not directly correlate with postoperative ARF, pre-OLT renal function (creatinine) emerged as a key predictor.
• Therapeutic strategies and patient selection for OLT may need to consider pre-transplant renal function more closely.
• The MELD system's impact on renal outcomes warrants further investigation, particularly concerning its indirect effects on patient management.